Palisade Bio, Inc.
PALI
Jodie situation report
Palisade Bio, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.
- PALI's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if PALI's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind PALI
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ABBVAbbVie Inc.competitorMar 20, 2026 ▾
“If approved for the treatment of patients with moderate-to-severe IBD, our portfolio of products would compete with TNF antibodies including Humira (AbbVie) and its biosimilars, Remicade (Johnson & Johnson) and its biosimilars, and Simponi (Johnson & Johnson)…”
BMYBristol-Myers Squibb CompanycompetitorMar 20, 2026 ▾
“If approved for the treatment of patients with moderate-to-severe IBD, our portfolio of products would compete with TNF antibodies including Humira (AbbVie) and its biosimilars, Remicade (Johnson & Johnson) and its biosimilars, and Simponi (Johnson & Johnson)…”
Depended on by
ANROAlto Neuroscience, Inc.partnerNov 12, 2025 ▾
“Palisade Asset Purchase Agreement In October 2021, we entered into an asset transfer agreement, or the Palisade Agreement, with Palisade Bio, Inc., or Palisade, pursuant to which we acquired all patent, know-how and other rights to ALTO-100.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
PALI is currently a Leader in the organic co-movement group Mass Spectrometry Technology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for PALI; it is not active in the latest market snapshot.